|
TYW1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.582600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.302200E-01 |
| Normal-vs-Stage2 |
4.475600E-01 |
| Normal-vs-Stage3 |
3.425400E-01 |
| Normal-vs-Stage4 |
3.915600E-01 |
| Stage1-vs-Stage2 |
8.118000E-01 |
| Stage1-vs-Stage3 |
7.086800E-01 |
| Stage1-vs-Stage4 |
7.852400E-01 |
| Stage2-vs-Stage3 |
9.751000E-01 |
| Stage2-vs-Stage4 |
9.956800E-01 |
| Stage3-vs-Stage4 |
9.656600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.662000E-01 |
| Normal-vs-AfricanAmerican |
2.436000E-01 |
| Normal-vs-Asian |
7.240600E-01 |
| Caucasian-vs-AfricanAmerican |
5.302200E-01 |
| Caucasian-vs-Asian |
9.513400E-01 |
| AfricanAmerican-vs-Asian |
8.683600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.054800E-01 |
| Normal-vs-Female |
5.154600E-01 |
| Male-vs-Female |
5.141600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.538200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.805800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.898600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.715600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.422800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.243000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.563200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.680400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.272600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.392200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.272570E-01 |
| Normal-vs-Grade 2 |
3.093800E-01 |
| Normal-vs-Grade 3 |
6.619600E-01 |
| Normal-vs-Grade 4 |
1.683370E-01 |
| Grade 1-vs-Grade 2 |
4.988000E-01 |
| Grade 1-vs-Grade 3 |
1.344580E-01 |
| Grade 1-vs-Grade 4 |
7.048200E-01 |
| Grade 2-vs-Grade 3 |
2.985000E-01 |
| Grade 2-vs-Grade 4 |
4.467600E-01 |
| Grade 3-vs-Grade 4 |
1.491810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.695000E-01 |
| Normal-vs-ccB subtype |
2.343800E-01 |
| ccA subtype-vs-ccB subtype |
2.870200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.548800E-01 |
| Normal-vs-N1 |
8.502800E-01 |
| N0-vs-N1 |
8.971800E-01 |
|
|
